Senate HELP Committee Asks RFK Jr. to Testify on HHS Reorganization Amid Mass Layoffs Including Up to One Third of HRSA Workforce

The Senate HELP Committee this week invited HHS Secretary Robert F. Kennedy Jr. to speak at an upcoming hearing on major restructuring at the Department of Health and Human Services, which included reportedly up to 600 layoffs at HRSA.
The leaders of a Senate panel that oversees several key federal health agencies this week invited Health and Human Services [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Arkansas Orders AstraZeneca to Restore 340B Drug Access at Contract Pharmacies

Arkansas Insurance Department Commissioner Alan McClain ordered AstraZeneca to “restore access to 340B drugs at all contract pharmacy delivery locations for Arkansas covered entities.”
An Arkansas state official yesterday ordered AstraZeneca to restore access to 340B drugs at all contract pharmacy locations, marking the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Apparent About-Face, HRSA Confirms Sagebrush’s 340B Eligibility During Federal Court Hearing

Sagebrush Health had sought emergency relief against the government to keep its clinic sites in the 340B program.
A federal judge yesterday delayed ruling on Sagebrush Health’s request for emergency relief after the government apparently reversed course and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Administration Creates New Agency Overseeing HRSA Amid Major HHS Staffing Cuts

HHS announced significant staffing cuts and restructuring that will merge HRSA with four other HHS divisions.
In a sweeping overhaul of the nation’s top government health agencies, the U.S. Department of Health and Human Services (HHS) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump-Aligned Think Tank Proposes Lowering U.S. Drug Prices Through IRA and Other Policies, Doesn’t Weigh In on 340B Program

America First Policy Institute released a March 21 brief detailing how policymakers “could accelerate drug development and enhance patient health by implementing reforms that discourage other countries from freeloading off American drug innovation.”
A conservative think tank, which officials who served in President Donald Trump’s (R) first administration founded to advance his priorities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump’s HHS Continues to Oppose Unilateral Drugmaker 340B Rebates in Kalderos Lawsuit

HHS filed a motion for summary judgement against Kalderos, the drug industry vendor behind Eli Lilly’s rebate proposal.
The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump Administration Opposes Unilateral Drugmaker 340B Rebates in First Legal Filing on Issue

HHS urged a federal court to dismiss lawsuits from Eli Lilly, Bristol Myers Squibb and Novartis seeking to implement 340B rebate models.
In the Trump administration’s first legal filing on drugmaker 340B rebates, the U.S. Department of Health and Human Services (HHS) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS Nominee ‘Dr. Oz’ Grilled Over Potential Medicaid Cuts and Position on Medicare Negotiations at Confirmation Hearing 

The Senate Finance Committee pressed Mehmet Oz, known as "Dr. Oz," on whether he would oppose cuts to Medicaid as CMS administrator. Oliver Oz, his son who is marketed as having a leadership role at a 340B services company, sat behind him during the hearing.
Mehmet Oz, President Donald Trump’s (R) nominee to lead the Centers for Medicare & Medicaid Services (CMS), faced persistent questioning—primarily [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo, J&J Announce 340B Refunds to Covered Entities

Sumitomo Pharma and Johnson & Johnson announced lists of drugs eligible for refunds.
Two drugmakers recently notified covered entities of adjustments to their 340B drug ceiling prices and resulting refund eligibility. Sumitomo Pharma [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Confirmation Hearing for Dr. Oz, Trump’s Pick to Lead CMS, Set for Tomorrow

The Senate Finance Committee announced it will hold a March 14 confirmation hearing on President Donald Trump's pick to lead CMS, Mehmet Oz.
Mehmet Oz, the celebrity heart surgeon and former U.S. Senate candidate that President Donald Trump nominated to lead the Centers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live